Welcome to LookChem.com Sign In|Join Free

CAS

  • or

82110-17-6

Post Buying Request

82110-17-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82110-17-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 82110-17-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,1,1 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 82110-17:
(7*8)+(6*2)+(5*1)+(4*1)+(3*0)+(2*1)+(1*7)=86
86 % 10 = 6
So 82110-17-6 is a valid CAS Registry Number.

82110-17-6Relevant articles and documents

Utilizing on- and off-line monitoring tools to follow a kinetic resolution step during flow synthesis

Farley, Kathleen A.,Reilly, Usa,Anderson, Dennis P.,Boscoe, Brian P.,Bundesmann, Mark W.,Foley, David A.,Lall, Manjinder S.,Li, Chao,Reese, Matthew R.,Yan, Jiangli

, p. 348 - 354 (2017)

In situ reaction monitoring tools offer the ability to track the progress of a synthetic reaction in real time to facilitate reaction optimization and provide kinetic/mechanistic insight. Herein, we report the utilization of flow NMR, flow IR, and other off-line spectroscopy tools to monitor the progress of a flow chemistry reaction. The on-line and off-line tools were selected to facilitate the stereoselective kinetic resolution of a key racemic monomer, which lacked a chromophore, making conventional reaction monitoring difficult. Copyright

NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS

-

Page/Page column 53; 54; 55, (2018/09/28)

The present invention provides novel imidazo[4,5-c]quinoline derivatives of Formula (I), and the pharmaceutically acceptable salts thereof I wherein R1, R2 and R3 are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of Formula I and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.

4-Methoxy-2-methyltetrahydropyrans: Chiral Leukotriene Biosynthesis Inhibitors, Related to ICI D2138, Which Display Enantioselectivity

Crawley, Graham C.,Briggs, Malcolm T.,Dowell, Robert I.,Edwards, Philip N.,Hamilton, Patricia M.,et al.

, p. 295 - 296 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82110-17-6